Report Detail
Implantable Biomaterials Global Market - Forecast to 2022
- RnM3925058 |
- 12 March, 2020 |
- Global |
- 497 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
A biomaterial is any substance of metallic, polymer, ceramic or natural origin that is suitable for introducing into living tissue as an implant without adversely affecting the patient. The biomaterial implants have been enormously successful and have enhanced the life of millions of patients. There is continuous ongoing research to develop next generation advanced biomaterials like bioabsorbable materials, bioactive and smart biomaterials, shape memory biomaterials etc. Next generation of biomaterials will have better prospect from the current research and innovations taking placing in biomaterials field.
This report concentrates on biomaterials that are used in the manufacturing of implant devices. The non-implant devices like catheters, guide wires and biomaterials in tissue engineering are not considered in implantable biomaterials report. Also, autografts and xenograft are not taken into account, only mass manufacture biomaterials are described in the report.
The Implantable Biomaterials market is classified based on type of materials, application, and geography. By material type, the market is segmented into Metal and Metal alloys, Synthetic Polymers, Ceramics, Natural biomaterials and Composites. By application, implantable biomaterials market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications. Geographical wise, the transplantation market is segmented into North America, Europe, Asia- Pacific and Rest of the world.
Among the implantable biomaterials by type, the synthetic polymers are dominating the market by occupying a largest share and synthetic polymers are expected to grow at a highest CAGR from 2015 to 2022. The synthetic polymers market by type is segmented into Polyetheretherketone, polytetrafluoroethylene, Polyethylene terephthalate, Polyethylene, Polymethylmethacrylate, Polyurethanes, Silicone, Resorbable polymers, Hydrogels and others. Among these, Polyetheretherketone accounts for major share in synthetic polymers segment and Resorbable polymers are expected to grow at strong CAGR from 2016 to 2023 . By applications, the market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications. Among these, Orthopedic application accounts for largest share of application market and Wound healing is growing at strong CAGR from 2016 to 2023.
The global implantable biomaterials market is expected to grow at single digit CAGR to reach $21,124.2 million by 2022. The factors driving the growth of this market are increasing ageing population, increase in Research and development investments, increasing applications of biomaterials, growing demand for plastic surgery, and reimbursements offered by Center for Medicare and Medicaid Services. However, stringent regulatory processes for approval of biomaterials and biomaterials based implant devices and limitations of biomaterials like complications due to implant rejection, cytotoxicity, and corrosion of biomaterials implant are hampering the growth of implantable biomaterials market.
The implantable biomaterials market is a highly fragmented market. Major players in Biomaterial market include Solvay Advanced Polymers, LLC (Belgium), Evonik Industries AG (Germany), Carpenter Technology Corporation (U.S.), DSM Biomedical, Inc. (Royal DSM) (Netherlands), Johnson Matthey Plc (U.K.), Morgan Advanced Materials plc (U.K.), Materion (U.S.), Victrex PLC (Invibio Biomaterial Solutions ) (U.K.) and Collagen solutions (U.K.), Corbion N.V. (Netherlands), Landec Corporation (U.S.).
1 EXECUTIVE SUMMARY 30
2 INTRODUCTION 36
- 2.1 KEY TAKEAWAYS 36
- 2.2 REPORT DESCRIPTION 37
- 2.3 MARKETS COVERED 39
- 2.4 STAKEHOLDERS 42
- 2.5 RESEARCH METHODOLOGY 42
- 2.5.1 MARKET SIZE ESTIMATION 44
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 46
- 2.5.3 SECONDARY SOURCES 47
- 2.5.4 PRIMARY SOURCES 48
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 48
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 49
- 2.5.7 ASSUMPTIONS 49
3 MARKET ANALYSIS 51
- 3.1 INTRODUCTION 51
- 3.2 MARKET SEGMENTATION 52
- 3.3 FACTORS INFLUENCING MARKET 54
- 3.3.1 DRIVERS AND OPPORTUNITIES 55
- 3.3.1.1 Advances in 3D printing of biomaterials 55
- 3.3.1.2 Increasing Aging Population 56
- 3.3.1.3 Miniaturization of implant devices and increasing minimally invasive surgery 56
- 3.3.1.4 Demand for Orthopedic Implants 57
- 3.3.1.5 Increasing R&D investments 58
- 3.3.2 RESTRAINTS AND THREATS 59
- 3.3.2.1 Limitations of biomaterial-base products 59
- 3.3.2.2 Stringent Regulatory Processes for Approval of Biomaterials & Biomaterial based products 60
- 3.3.1 DRIVERS AND OPPORTUNITIES 55
- 3.4 REGULATORY AFFAIRS 60
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 60
- 3.4.2 U.S. 62
- 3.4.3 EUROPE 64
- 3.4.4 CHINA 65
- 3.4.5 CANADA 66
- 3.4.6 INDIA 66
- 3.5 TECHNOLOGICAL ADVANCEMENTS 67
- 3.5.1 INTRODUCTION 67
- 3.5.2 SMART BIOMATERIALS 68
- 3.5.3 SHEAR-THINNING BIOMATERIALS (STB) 68
- 3.6 PORTER’S FIVE FORCE ANALYSIS 69
- 3.6.1 THREAT OF NEW ENTRANTS 70
- 3.6.2 THREAT OF SUBSTITUTES 71
- 3.6.3 BARGAINING POWER OF SUPPLIERS 72
- 3.6.4 BARGAINING POWER OF BUYERS 72
- 3.6.5 RIVALRY AMONG EXISTING COMPETITORS 73
- 3.7 SUPPLY CHAIN ANALYSIS 74
- 3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 77
4 IMPLANTABLE BIOMATERIALS GLOBAL MARKET, BY SOURCE 79
- 4.1 INTRODUCTION 79
- 4.2 METALS AND METAL ALLOYS 82
- 4.2.1 TITANIUM AND TITANIUM ALLOYS 87
- 4.2.2 COBALT-CHROME ALLOYS 90
- 4.2.3 STAINLESS STEEL 92
- 4.2.4 MAGNESIUM AND MAGNESIUM ALLOYS 93
- 4.2.5 OTHER METALLIC BIOMATERIALS 96
- 4.3 SYNTHETIC POLYMERS 98
- 4.3.1 INTRODUCTION 98
- 4.3.2 POLYETHERETHERKETONE (PEEK) 103
- 4.3.3 POLYTETRAFLU0ROETHYLENE (PTFE) 105
- 4.3.4 POLYETHYLENE TEREPHTHALATE (PETE) 107
- 4.3.5 POLYETHYLENE (UHMWPE) 109
- 4.3.6 POLYMETHYLMETHACRYLATE (PMMA) 111
- 4.3.7 POLYURETHANES 113
- 4.3.8 SILICONE 114
- 4.3.9 RESORBABLE POLYMERS 116
- 4.3.10 HYDROGELS 119
- 4.3.11 OTHER SYNTHETIC POLMERS 120
- 4.4 CERAMICS 122
- 4.4.1 CALCIUM COMPOSITIONS 127
- 4.4.2 ALUMINUM OXIDE 129
- 4.4.3 ZIRCONIA 131
- 4.4.4 CARBON 133
- 4.4.5 GLASS 135
- 4.4.6 SILICON NITRIDE 137
- 4.5 NATURAL BIOMATERIALS 139
- 4.5.1 INTRODUCTION 139
- 4.5.2 CELLULOSE 144
- 4.5.3 COLLAGEN AND GELATIN 146
- 4.5.4 HYALURONIC ACID 148
- 4.5.5 FIBRIN 150
- 4.5.6 CHITIN/CHITOSAN 152
- 4.5.7 ELASTIN 153
- 4.5.8 SILK 154
- 4.5.9 OTHER NATURAL BIOMATERIALS 155
- 4.6 COMPOSITES 156
5 IMPLANTABLE BIOMATERIALS GLOBAL MARKET, BY APPLICATION 159
- 5.1 INTRODUCTION 159
- 5.2 CARDIOVASCULAR 162
- 5.2.1 STENTS 166
- 5.2.2 HEART VALVE REPAIR AND REPLACEMENT 167
- 5.2.3 VASCULAR GRAFTS 170
- 5.2.4 PACMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
(ICDS) 171
- 5.2.5 OTHERS 173
- 5.3.1 JOINT REPAIR AND REPLACEMENT 179
- 5.3.2 SPINE 181
- 5.3.3 ORTHOBIOLOGICS 183
- 5.3.4 OTHER ORTHOPEDIC APPLICATION 186
- 5.4.1 DENTAL IMPLANTS 191
- 5.4.2 DENTAL BONE GRAFTS AND SUBSTITUTES 193
- 5.4.3 DENTAL MEMBRANES 194
- 5.5.1 BIOENGINEERED SKINS 199
- 5.5.2 SOFT TISSSUE FILLERS 201
- 5.5.3 COSMETIC IMPLANTS 202
- 5.5.4 CRANIOFACIAL SURGERY 204
- 5.6.1 WOUND CLOSURE 209
- 5.6.1.1 Sutures 211
- 5.6.1.2 Staples 214
- 5.6.1.3 Ligating clips 216
- 5.6.2 SYNTHETIC SKIN SUBSTITUTES 218
- 5.6.3 TAPES AND ADHESIVES 220
- 5.6.4 HEMOSTATS 222
- 5.6.5 SEALANTS 224
- 5.7.1 CONTACT LENS 230
- 5.7.2 INTRAOCULAR LENS 232
- 5.7.3 OCULAR REPLACEMENT 234
- 5.7.4 SYNTHETIC CORNEA 236
- 5.7.5 VITREOUS BODY REPLACEMENT 238
- 5.8.1 SHUNTING SYSTEMS 244
- 5.8.2 CORTICAL NEURAL PROSTHETICS 246
- 5.8.3 NERVE CONDUITS 248
- 5.9.1 GASTROINTESTINAL 254
- 5.9.2 SURGICAL MESH 257
- 5.9.3 COCHLEAR IMPLANT 259
- 5.9.4 IMPLANTABLE INFUSION PUMPS 261
- 5.9.5 OTHER STENTS AND VASCULAR GRAFTS 263
- 5.9.6 OTHERS 265
6 REGIONAL ANALYSIS 268
- 6.1 INTRODUCTION 268
- 6.2 NORTH AMERICA 271
- 6.2.1 U.S. 291
- 6.2.2 OTHERS 296
- 6.3 EUROPE 301
- 6.3.1 GERMANY 321
- 6.3.2 U.K. 326
- 6.3.3 FRANCE 331
- 6.3.4 OTHERS 336
- 6.4 ASIA - PACIFIC 341
- 6.4.1 JAPAN 361
- 6.4.2 CHINA 366
- 6.4.3 INDIA 371
- 6.4.4 OTHERS 376
- 6.5 REST OF THE WORLD 381
- 6.5.1 LATIN AMERICA 401
- 6.5.2 MIDDLE EAST 406
- 6.5.3 OTHERS 411
7 MAJOR COMPANIES 415
- 7.1 CARPENTER TECHNOLOGY CORPORATION 415
- 7.1.1 OVERVIEW 415
- 7.1.2 FINANCIALS 416
- 7.1.3 PRODUCT PORTFOLIO 419
- 7.1.4 KEY DEVELOPMENTS 421
- 7.1.5 BUSINESS STRATEGY 421
- 7.1.6 SWOT ANALYSIS 422
- 7.2 COLLAGEN SOLUTIONS 423
- 7.2.1 OVERVIEW 423
- 7.2.2 FINANCIALS 424
- 7.2.3 PRODUCT PORTFOLIO 426
- 7.2.4 KEY DEVELOPMENTS 427
- 7.2.5 BUSINESS STRATEGY 430
- 7.2.6 SWOT ANALYSIS 431
- 7.3 CORBION NV 432
- 7.3.1 OVERVIEW 432
- 7.3.2 FINANCIALS 433
- 7.3.3 PRODUCT PORTFOLIO 436
- 7.3.4 KEY DEVELOPMENTS 437
- 7.3.5 BUSINESS STRATEGY 438
- 7.3.6 SWOT ANALYSIS 439
- 7.4 EVONIK INDUSTRIES AG 440
- 7.4.1 OVERVIEW 440
- 7.4.2 FINANCIALS 441
- 7.4.3 PRODUCT PORTFOLIO 444
- 7.4.4 KEY DEVELOPMENTS 445
- 7.4.5 BUSINESS STRATEGY 447
- 7.4.6 SWOT ANALYSIS 448
- 7.5 JOHNSON MATTHEY PLC 449
- 7.5.1 OVERVIEW 449
- 7.5.2 FINANCIALS 450
- 7.5.3 PRODUCT PORTFOLIO 453
- 7.5.4 KEY DEVELOPMENTS 453
- 7.5.5 BUSINESS STRATEGY 453
- 7.5.6 SWOT ANALYSIS 454
- 7.6 LANDEC CORPORATION 455
- 7.6.1 OVERVIEW 455
- 7.6.2 FINANCIALS 456
- 7.6.3 PRODUCT PORTFOLIO 457
- 7.6.4 KEY DEVELOPMENTS 457
- 7.6.5 BUSINESS STRATEGY 458
- 7.6.6 SWOT ANALYSIS 458
- 7.7 MATERION CORPORATION 459
- 7.7.1 OVERVIEW 459
- 7.7.2 FINANCIALS 460
- 7.7.3 PRODUCT PORTFOLIO 462
- 7.7.4 KEY DEVELOPMENTS 463
- 7.7.5 BUSINESS STRATEGY 463
- 7.7.6 SWOT ANALYSIS 464
- 7.8 MORGAN ADVANCED MATERIALS PLC 465
- 7.8.1 OVERVIEW 465
- 7.8.2 FINANCIALS 466
- 7.8.3 PRODUCT PORTFOLIO 469
- 7.8.4 KEY DEVELOPMENTS 469
- 7.8.5 BUSINESS STRATEGY 470
- 7.8.6 SWOT ANALYSIS 471
- 7.9 ROYAL DSM BIOMEDICAL 472
- 7.9.1 OVERVIEW 472
- 7.9.2 FINANCIALS 473
- 7.9.3 PRODUCT PORTFOLIO 476
- 7.9.4 KEY DEVELOPMENTS 477
- 7.9.5 BUSINESS STRATEGY 478
- 7.9.6 SWOT ANALYSIS 479
- 7.10 SOLVAY SA 480
- 7.10.1 OVERVIEW 480
- 7.10.2 FINANCIALS 481
- 7.10.3 PRODUCT PORTFOLIO 485
- 7.10.4 KEY DEVELOPMENTS 485
- 7.10.5 BUSINESS STRATEGY 487
- 7.10.6 SWOT ANALYSIS 488
- 7.11 VICTREX PLC 489
- 7.11.1 OVERVIEW 489
- 7.11.2 FINANCIALS 490
- 7.11.3 PRODUCT PORTFOLIO 492
- 7.11.4 KEY DEVELOPMENTS 493
- 7.11.5 BUSINESS STRATEGY 494
Summary:
Get latest Market Research Reports on Implantable Biomaterials. Industry analysis & Market Report on Implantable Biomaterials is a syndicated market report, published as Implantable Biomaterials Global Market - Forecast to 2022. It is complete Research Study and Industry Analysis of Implantable Biomaterials market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
